Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Hemorrhagic transformation during thrombolytic therapy and reperfusion: effects of age, blood pressure, and matrix metalloproteinases.

Lyden PD.

J Stroke Cerebrovasc Dis. 2013 May;22(4):532-8. doi: 10.1016/j.jstrokecerebrovasdis.2013.02.001. Epub 2013 Mar 1.

PMID:
23453556
2.

The association of periprocedural hypertension and adverse outcomes in patients undergoing catheter-directed thrombolysis.

Agle SC, McNally MM, Powell CS, Bogey WM, Parker FM, Stoner MC.

Ann Vasc Surg. 2010 Jul;24(5):609-14. doi: 10.1016/j.avsg.2009.12.011. Epub 2010 Apr 22.

PMID:
20413257
3.

Effect of the duration of middle cerebral artery occlusion on the risk of hemorrhagic transformation after tissue plasminogen activator injection in rats.

Copin JC, Gasche Y.

Brain Res. 2008 Dec 3;1243:161-6. doi: 10.1016/j.brainres.2008.09.025. Epub 2008 Sep 19.

PMID:
18835259
4.

Brain hemorrhages after rt-PA treatment of embolic stroke in spontaneously hypertensive rats.

Brinker G, Pillekamp F, Hossmann KA.

Neuroreport. 1999 Jun 23;10(9):1943-6.

PMID:
10501537
5.

Safety of low-frequency transcranial ultrasound in permanent middle cerebral artery occlusion in spontaneously hypertensive rats.

Wang Z, Fukuda T, Azuma T, Furuhata H.

Cerebrovasc Dis. 2012;33(1):23-9. doi: 10.1159/000332034. Epub 2011 Nov 30.

PMID:
22133698
6.
8.

Endogenous activated protein C predicts hemorrhagic transformation and mortality after tissue plasminogen activator treatment in stroke patients.

Mendioroz M, Fernández-Cadenas I, Alvarez-Sabín J, Rosell A, Quiroga D, Cuadrado E, Delgado P, Rubiera M, Ribó M, Molina C, Montaner J.

Cerebrovasc Dis. 2009;28(2):143-50. doi: 10.1159/000225907. Epub 2009 Jun 19.

PMID:
19546541
9.

Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.

Pundik S, McWilliams-Dunnigan L, Blackham KL, Kirchner HL, Sundararajan S, Sunshine JL, Tarr RW, Selman WR, Landis DM, Suarez JI.

J Stroke Cerebrovasc Dis. 2008 Sep;17(5):266-72. doi: 10.1016/j.jstrokecerebrovasdis.2008.03.003.

PMID:
18755405
10.

TGF-β1 prevents blood-brain barrier damage and hemorrhagic transformation after thrombolysis in rats.

Cai Y, Liu X, Chen W, Wang Z, Xu G, Zeng Y, Ma Y.

Exp Neurol. 2015 Apr;266:120-6. doi: 10.1016/j.expneurol.2015.02.013. Epub 2015 Feb 20.

PMID:
25708985
12.

Drop of PT Quick percent value is associated with both symptomatic and asymptomatic intracranial hemorrhage in patients treated with rt-PA for acute ischemic stroke.

Alonso A, Dempfle CE, Szabo K, Zohsel K, Hennerici MG.

Thromb Res. 2011 Jan;127(1):65-6. doi: 10.1016/j.thromres.2010.04.018. No abstract available.

PMID:
20537372
13.

Rivaroxaban and apixaban reduce hemorrhagic transformation after thrombolysis by protection of neurovascular unit in rat.

Kono S, Yamashita T, Deguchi K, Omote Y, Yunoki T, Sato K, Kurata T, Hishikawa N, Abe K.

Stroke. 2014 Aug;45(8):2404-10. doi: 10.1161/STROKEAHA.114.005316. Epub 2014 Jul 1.

14.

Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.

Zhang Y, Wang Y, Zuo Z, Wang Z, Roy J, Hou Q, Tong E, Hoffmann A, Sperberg E, Bredno J, Berr SS, Xie M, Lee K, Wintermark M.

J Neurol Sci. 2014 Dec 15;347(1-2):148-54. doi: 10.1016/j.jns.2014.09.036. Epub 2014 Sep 28.

PMID:
25292413
15.

Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke?

Hassan AE, Chaudhry SA, Jani V, Grigoryan M, Khan AA, Adil MM, Qureshi AI.

J Stroke Cerebrovasc Dis. 2013 May;22(4):545-9. doi: 10.1016/j.jstrokecerebrovasdis.2013.01.022. Epub 2013 Feb 28.

PMID:
23453555
16.

Tacrolimus (FK506) suppresses rt-PA-induced hemorrhagic transformation in a rat thrombotic ischemia stroke model.

Maeda M, Furuichi Y, Noto T, Matsuoka N, Mutoh S, Yoneda Y.

Brain Res. 2009 Feb 13;1254:99-108. doi: 10.1016/j.brainres.2008.11.080. Epub 2008 Dec 3.

PMID:
19101526
18.

A model to prevent fibrinolysis in patients with stroke mimics.

Chang J, Teleb M, Yang JP, Alderazi YJ, Chapple K, Frey JL, Restrepo L.

J Stroke Cerebrovasc Dis. 2012 Nov;21(8):839-43. doi: 10.1016/j.jstrokecerebrovasdis.2011.04.018. Epub 2011 Jun 2.

PMID:
21640609
19.

Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy.

Masrur S, Abdullah AR, Smith EE, Hidalgo R, El-Ghandour A, Rordorf G, Schwamm LH.

J Stroke Cerebrovasc Dis. 2011 Mar-Apr;20(2):124-30. doi: 10.1016/j.jstrokecerebrovasdis.2009.10.010. Epub 2010 Jul 3.

PMID:
20598579
20.

Combined therapy with PJ34, a poly(ADP-ribose)polymerase inhibitor, reduces tissue plasminogen activator-induced hemorrhagic transformations in cerebral ischemia in mice.

Haddad M, Beray-Berthat V, Coqueran B, Plotkine M, Marchand-Leroux C, Margaill I.

Fundam Clin Pharmacol. 2013 Aug;27(4):393-401. doi: 10.1111/j.1472-8206.2012.01036.x. Epub 2012 Mar 21.

PMID:
22436003

Supplemental Content

Support Center